Iimpawu zoMsebenzi
Umda wokufumanisa: 0.3 pmol/L;
Uluhlu lomgca: 0.3-100.0 pmol / L;
I-coefficient yokulungelelanisa yomgca R ≥ 0.990;
Ukuchaneka: ngaphakathi kwe-batch CV ngu ≤ 15%;phakathi kweebhetshi iCV yi ≤ 20%;
Ukuchaneka: ukutenxa okunxulumeneyo kweziphumo zomlinganiselo akusayi kudlula ± 15% xa isilinganisi sokuchaneka esilungiswe ngumgangatho wesizwe we-FT4 okanye isilinganisi sokuchaneka esisemgangathweni sivavanywa.
I-Cross-Reactivity: Ezi zinto zilandelayo aziphazamisi iziphumo zovavanyo lwe-T4 kwiindawo ezibonisiweyo: TT3 ku-500ng/mL, rT3 ku-50ng/mL.
1. Gcina i-Aehealth FT4 Rapid Quantitative test cassette kwi-2～30℃, ubomi beshelufu bufikelela kwiinyanga ezili-18.
2. Ikhasethi yovavanyo kufuneka isetyenziswe kwiyure enye emva kokuvula ipakethi.
Ukuzimisela kwe-serum okanye amanqanaba e-plasma ye-Thyroxine (T4) ibonwa njengomlinganiselo obalulekileyo ekuhloleni umsebenzi we-thyroid.I-Thyroxine (T4) yenye yeehomoni ezimbini ezinkulu eziveliswa lidlala lengqula (enye ibizwa ngokuba yi-triiodothyronine, okanye i-T3), i-T4 kunye ne-T3 zilawulwa yinkqubo yempendulo ebuthathaka ebandakanya i-hypothalamus kunye nedlala lepituitary.I-T4 yamahhala ilinganiswa kunye ne-TSH xa ukuphazamiseka komsebenzi we-thyroid kukrokrelwa.Ukuzimisela kwe-fT4 kukwafanelekile ukubeka iliso kwi-thyrosuppressive therapy.Ukuzimisela kwe-T4 yamahhala kunenzuzo yokuzimela ngokuzimeleyo kwiinguqu kwiimpawu kunye neepropati ezibophezelayo zeeprotheni ezibophezelayo;